Archive · 25 Jul 2025
Laurus Labs Reports Significant Profit Increase in Q1 FY26
Laurus Labs, a company based in Hyderabad, made a lot more money in the first few months of the year!
Their profits jumped up to ₹163 crore, much higher than the previous year.
They also sold more stuff, increasing their income by 31%.
This good news is thanks to their CDMO business and selling more finished medicines.
The company is now focused on making the most of its opportunities, growing its business, and improving technology.
They also have plans to build new facilities.
The company's finances look good, and they plan to invest to keep growing.
Laurus Labs' net profit increased to ₹163 crore in Q1 FY26.
Revenue increased by 31% to ₹1570 crore.
Growth driven by CDMO business and Generic Finished Dosage Forms.
Company is focusing on commercial execution and business development.
EBITDA margins improved to 24.8%.
- Who
- Laurus Labs.
- What
- Laurus Labs' net profit increased in Q1 FY26.
- When
- In the first quarter ended June 30, 2025.
- Where
- Hyderabad.
- Why
- Driven by increasing contributions from the Contract Development and Manufacturing Organisation (CDMO) business and Generic Finished Dosage Forms (FDF).
- Net Profit Q1 FY26
- ₹163 crore
- Net Profit Q1 FY25
- ₹13 crore
- Revenue Increase
- 31%
- Revenue Amount
- ₹1570 crore
- EBITDA Margins
- 24.8%
- Gross Margins
- 59.4%
- CEO
- Satyanarayana Chava